A detailed history of Captrust Financial Advisors transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 4,833 shares of ALNY stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,833
Previous 3,596 34.4%
Holding current value
$1.18 Million
Previous $873,000 52.23%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$233.81 - $287.01 $289,222 - $355,031
1,237 Added 34.4%
4,833 $1.33 Million
Q2 2024

Aug 14, 2024

SELL
$143.31 - $247.0 $6,162 - $10,621
-43 Reduced 1.18%
3,596 $873,000
Q1 2024

May 15, 2024

SELL
$146.51 - $198.2 $142,847 - $193,245
-975 Reduced 21.13%
3,639 $543,000
Q4 2023

Feb 14, 2024

BUY
$151.41 - $196.57 $64,652 - $83,935
427 Added 10.2%
4,614 $883,000
Q3 2023

Nov 14, 2023

SELL
$170.77 - $211.65 $125,345 - $155,351
-734 Reduced 14.92%
4,187 $741,000
Q2 2023

Aug 14, 2023

BUY
$185.01 - $212.05 $506,187 - $580,168
2,736 Added 125.22%
4,921 $934,000
Q1 2023

May 15, 2023

BUY
$182.66 - $235.53 $104,116 - $134,252
570 Added 35.29%
2,185 $437,000
Q4 2022

Feb 15, 2023

BUY
$185.53 - $241.31 $25,974 - $33,783
140 Added 9.49%
1,615 $383,000
Q3 2022

Nov 16, 2022

BUY
$138.54 - $232.0 $26,322 - $44,080
190 Added 14.79%
1,475 $295,000
Q2 2022

Aug 23, 2022

SELL
$120.42 - $169.29 $22,638 - $31,826
-188 Reduced 12.76%
1,285 $187,000
Q2 2022

Aug 16, 2022

BUY
$120.42 - $169.29 $29,021 - $40,798
241 Added 19.56%
1,473 $215,000
Q1 2022

May 16, 2022

BUY
$127.18 - $173.91 $41,842 - $57,216
329 Added 36.43%
1,232 $201,000
Q4 2021

Feb 14, 2022

BUY
$159.56 - $209.29 $7,978 - $10,464
50 Added 5.86%
903 $153,000
Q3 2021

Nov 16, 2021

BUY
$169.75 - $207.73 $25,632 - $31,367
151 Added 21.51%
853 $161,000
Q2 2021

Aug 16, 2021

BUY
$128.63 - $176.89 $4,630 - $6,368
36 Added 5.41%
702 $119,000
Q1 2021

May 17, 2021

BUY
$126.83 - $175.69 $63,795 - $88,372
503 Added 308.59%
666 $94,000
Q4 2020

Feb 16, 2021

SELL
$122.97 - $147.0 $7,378 - $8,820
-60 Reduced 26.91%
163 $21,000
Q2 2020

Aug 14, 2020

BUY
$104.21 - $156.44 $23,238 - $34,886
223 New
223 $33,000
Q4 2019

Feb 14, 2020

SELL
$74.51 - $124.23 $65,792 - $109,695
-883 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$70.9 - $87.82 $51,969 - $64,372
733 Added 488.67%
883 $71,000
Q3 2017

Feb 16, 2018

BUY
$72.53 - $118.27 $10,879 - $17,740
150
150 $18,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.